The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liquid biopsies (LB) across treatment of 29 metastatic colorectal cancer (mCRC) patients (pts) to reveal driver mutations and tumor evolution with anti-EGFR therapy: Experience in a GI oncology clinic at Fox Chase Cancer Center.
 
Pooja Ghatalia
No Relationships to Disclose
 
Arthur Winer
No Relationships to Disclose
 
Chad Smith
No Relationships to Disclose
 
Jiangtao Gou
No Relationships to Disclose
 
Lesli Ann Kiedrowski
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Patricia D Saltzberg
No Relationships to Disclose
 
Nicole Bubes
No Relationships to Disclose
 
Fern Anari
No Relationships to Disclose
 
Vineela Kasireddy
No Relationships to Disclose
 
Asya Varshavsky
No Relationships to Disclose
 
Eric A. Ross
No Relationships to Disclose
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Oncoceutics; p53-Therapeutics
Research Funding - Bayer; Loxo; Morphotek; Tarmeta Biosciences
Patents, Royalties, Other Intellectual Property - Patent on TIC10 (ONC201); Patents pending on the use of small molecules to target mutant p53
Other Relationship - Caris Life Sciences